Research Symposium Program - Individual Details
5th annual Undergraduate Research Symposium, April 17, 2025
Cheyenne Sapp https://pc.fsu.edu/student-research/symposium/symposium-program-2025/dnap
BIO
I am a student in the Class of 2025- Doctor of Nurse Anesthesia Practice at Florida State University. I am passionate about the practice of anesthesia and furthering evidence based practice through research. I plan to practice in my hometown of Dothan, Alabama upon graduation.
Post-Anesthesia Care Unit Times in Patients Reversed from Aminosteroid Paralytics with Sugammadex versus Neostigmine and Glycopyrrolate Combination
Authors: Cheyenne Sapp, Dr. Jason Smith, DNAP, APRN, CRNAStudent Major: Doctorate of Nurse Anesthesia Practice
Mentor: Dr. Jason Smith, DNAP, APRN, CRNA
Mentor's Department: Nurse Anesthesia Mentor's College: Florida State University Co-Presenters: Shelby Ragan, SRNA
Abstract
Neuromuscular blockade (NMB) reversal is vital for anesthesia care to prevent residual blockade, which can lead to respiratory complications and delayed recovery. This quality improvement project evaluated sugammadex, a selective NMB reversal agent, compared to the traditional neostigmine-glycopyrrolate, focusing on postoperative care unit (PACU) times in adult patients undergoing general anesthesia with rocuronium or vecuronium. Evidence from clinical guidelines and studies supported sugammadex's advantages in efficiency, safety, and cost-effectiveness. Implemented at a facility in Dothan, Alabama, the project addressed financial concerns through education, aiming to increase sugammadex utilization. Usage increased modestly by 1.38% (from 434 to 440 cases), reflecting improved provider confidence and highlighting the value of overcoming barriers to enhance patient safety and operating room efficiency.
Keywords: Reversal, Neostigmine, Glycopyrrolate, Sugammadex